CrossRef The impact of metabolic dysfunction-associated steatotic liver disease on the efficacy of pegylated interferon-based therapy in patients with chronic hepatitis B Jiaxin Han, Lianxin Xu, Yuqin Li, Ziling Wang, Minghui Zeng, Jieru Gao, Yuqiang Mi, Wentao Kuai, Huiling Xiang, Liang Xu Frontiers in Immunology .2026;[Epub] CrossRef Type 2 diabetes as a key metabolic risk factor for adverse outcomes in nucleos(t)ide analogue-treated chronic hepatitis B: Editorial on Impacts of metabolic syndrome diseases on long-term outcomes of chronic hepatitis B patients treated with nucleos(t)id Heejoon Jang, Won Kim Clinical and Molecular Hepatology .2026
This antioxidant action helps reduce harmful compounds in liver cells, which facilitates the removal of toxins and supports the regeneration of tissues
Dose escalation should be a clinical decision, not a self-directed one
There were 23 clinical studies published between 2020 and 2025 that support collagen as a nutraceutical treatment that showed improvement in various skin attributes, but investigations are lacking on collagens effectiveness on scalp, hair, and nail health, which warrants further examination
Choosing the right clinic is as important as choosing the right formula